[1] WANG Pei,.Research on Cannabinoids Hotspot Issues Based on???? Word Frequency Analysis and Co Word Clustering [J]. Journal of Shaanxi University of Traditional Chinese Medicine, 2023, (06): 28-35. [doi: 10.13424/j.cnki.jsctcm.2023.06.006]
Copy

Research on Cannabinoids Hotspot Issues Based on???? Word Frequency Analysis and Co Word Clustering

References:

[1]陈青阳,郑琴,杨明,等.大麻古今临床应用概述[J].江西中医学院学报,2008,20(6):86-88.
[2]Jackson SJ,Diemel LT,Pryce G,et al.Cannabinoids and neuroprotection in CNS inflammatory disease[J].Journal of the Neurological Sciences,2005,233(1/2):21-25.
[3]Falenski KW,Carter DS,Harrison AJ,et al.Temporal characterization of changes in hippocampal cannabinoid CB1 receptor expression following pilocarpine-induced status epilepticus[J].Brain Research,2009,1262:64-72.
[4]Witting A,Chen LF,Cudaback E,et al.Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection[J].Proceedings of the National Academy of Sciences of the United States of America,2006,103(16):6362-6367.
[5]Loría F,Petrosino S,Mestre L,et al.Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide[J].The European Journal of Neuroscience,2008,28(4):633-641.
[6]Hill MN,Hillard CJ,Bambico FR,et al.The therapeutic potential of the endocannabinoidsystem for the development of a novel class of antidepressants[J].Trends in Pharmacological Sciences,2009,30(9):484-493.
[7]Lutz B.Endocannabinoid signals in the control of emotion[J].Current Opinion in Pharmacology,2009,9(1):46-52.
[8]RomeroZerbo SY,BermúdezSilva FJ.Cannabinoids,eating behaviour,and energy homeostasis[J].Drug Testing and Analysis,2014,6(1/2):52-58.
[9]刘萍,边强.大麻素类药物的治疗作用[J].药学进展,2002,26(2):99-101.
[10]Graham E,Ashton J,Glass M.Cannabinoid Receptors:a brief history and “what & apos;s hot”[J].Frontiers in Bioscience,2009,14(3):944-57.
[11]Moreno E,Andradas C,Medrano M,et al.Targeting CB2GPR55 receptor heteromers modulates cancer cell signaling[J].Journal of Biological Chemistry,2014,289(32):21960-21972.
[12]Pertwee RG.The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids:delta9-tetrahydrocannabinol,cannabidiol and delta9-tetrahydrocannabivarin[J].British Journal of Pharmacology,2008,153(2):199-215.
[13]Ashton JC,Friberg D,Darlington CL,et al.Expression of the cannabinoid CB2 receptor in the rat cerebellum:an immunohistochemical study[J].Neuroscience Letters,2006,396(2):113-116.
[14]Gong JP,Onaivi ES,Ishiguro H,et al.Cannabinoid CB2 receptors:Immunohistochemical localization in rat brain[J].Brain Research,2006,1071(1):10-23.
[15]Baek JH,Zheng YW,Darlington CL,et al.Cannabinoid CB2 receptor expression in the rat brainstem cochlear and vestibular nuclei[J].Acta OtoLaryngologica,2008,128(9):961-967.
[16]Brown AJ.Novel cannabinoid receptors[J].British Journal of Pharmacology,2007,152(5):567-575.
[17]Klumpers LE,Roy C,Ferron G,et al.Surinabant,a selective cannabinoid receptor type 1 antagonist,inhibitsΔ9-tetrahydrocannabinolinduced central nervous system and heart rate effects in humans[J].British Journal of Clinical Pharmacology,2013,76(1):65-77.
[18]Wallace JL,Flannigan KL,McKnight W,et al.Pro’resolution,protective and antinociceptive effects of a Cannabis extract in the rat gastrointestinal tract[J].Journal of Physiology and Pharmacology:an Official Journal of the Polish Physiological Society,2013,64(2):167-175.
[19]那一沙,袁玫,杜修平.基于词频分析和共词聚类的教学设计热点问题的研究[J].现代教育技术,2013,23(3):31-35.
[20]马费成,张勤.国内外知识管理研究热点:基于词频的统计分析[J].情报学报,2006(2):163-171.
[21]钟伟金,李佳,杨兴菊.共词分析法研究(三):共词聚类分析法的原理与特点[J].情报杂志,2008,27(7):118-120.
[22]林聚任.社会网络分析:理论、方法与应用[M].北京:北京师范大学出版社,2009:49-50.
[23]刘启元,叶鹰.文献题录信息挖掘技术方法及其软件SATI的实现:以中外图书情报学为例[J].信息资源管理学报,2012,2(1):50-58.
[24]di Marzo V.CB1 receptor antagonism:biological basis for metabolic effects[J].Drug Discovery Today,2008,13(23/24):1026-1041.
[25]吴永涛.大麻素CB1、CB2受体在脑组织中分布及其表达特性的研究[D].重庆:第三军医大学,2009.
[26]王宇卉,邵福源.大麻素系统及其在神经系统疾病中的治疗前景[J].世界临床药物,2008,29(4):224-228.
[27]Begg M,Pacher P,Bátkai S,et al.Evidence for novel cannabinoid receptors[J].Pharmacology & Therapeutics,2005,106(2):133-145.
[28]唐双奇,陆阳.内源性大麻素—生物合成、信号转导及生物降解[J].中国药理学通报,2013,29(8):1037-1041.
[29]Caulfield MP,Brown DA.Cannabinoid receptor agonists inhibit Ca current in NG108-15 neuroblastoma cells via a pertussis toxinsensitive mechanism[J].British Journal of Pharmacology,1992,106(2):231-232.
[30]Mackie K,Hille B.Cannabinoids inhibit Ntype calcium channels in neuroblastomaglioma cells[J].Proceedings of the National Academy of Sciences of the United States of America,1992,89(9):3825-3829.
[31]Mackie K,Lai Y,Westenbroek R,et al.Cannabinoidsactivate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor[J].The Journal of Neuroscience:the Official Journal of the Society for Neuroscience,1995,15(10):6552-6561.
[32]Deadwyler SA,Hampson RE,Mu J,et al.Cannabinoids modulate voltage sensitive potassium Acurrent in hippocampal neurons via a cAMPdependent process[J].The Journal of Pharmacology and Experimental Therapeutics,1995,273(2):734-743.
[33]Paik HD,ParkJS,Park E.Effects of Bacillus polyfermenticus SCD on lipid and antioxidant metabolisms in rats fed a highfat and highcholesterol diet[J].Biological & Pharmaceutical Bulletin,2005,28(7):1270-1274.
[34]Chen J,Zhang RM,Chen XY,et al.Heterodimerization of human orexin receptor 1 and kappa opioid receptor promotes protein kinase A/cAMP-response element binding protein signaling via a Gαsmediated mechanism[J].Cellular Signalling,2015,27(7):1426-1438.
[35]朱飞,王湘庆,陈亚楠,等.大麻素受体1/食欲素受体1-G蛋白偶联受体异聚体及其交叉激活作用研究进展[J].解放军医学院学报,2015,36(1):94-96.
[36]Seywright A,Torrance HJ,Wylie FM,et al.Analysis and clinical findings of cases positive for the novel synthetic cannabinoid receptor agonist MDMBCHMICA[J].Clinical Toxicology,2016,54(8):632-637.
[37]Giorgetti A,Busardò FP,Tittarelli R,et al.Postmortem toxicology:a systematic review of death cases involving synthetic cannabinoid receptor agonists[J].Frontiers in Psychiatry,2020,11:464.
[38]Wouters E,Walraed J,Banister SD,et al.Insights into biased signaling at cannabinoid receptors:synthetic cannabinoid receptor agonists[J].Biochemical Pharmacology,2019,169:113623.
[39]Eldeeb K,LeoneKabler S,Howlett AC.Cannabinoid receptor antagonists and G protein subtypes[J].The FASEB Journal,2019,33(S1):lb392-lb392.
[40]Porcu A,Melis M,Turecek R,et al.Rimonabant,a potent CB1 cannabinoid receptor antagonist,is a Gαi/o protein inhibitor[J].Neuropharmacology,2018,133:107-120.
[41]Dawidowicz AL,Olszowy-Tomczyk M,Typek R.CBG,CBD,Δ9-THC,CBN,CBGA,CBDA and Δ9-THCA as antioxidant agents and their intervention abilities in antioxidant action[J].Fitoterapia,2021,152:104915.
[42]Robaina Cabrera CL,Keir-Rudman S,Horniman N,et al.The anti’inflammatory effects of cannabidiol and cannabigerol alone,and in combination[J].Pulmonary Pharmacology & Therapeutics,2021,69:102047.
[43]Zhou C,Assareh N,Arnold JC.The Cannabis constituent cannabigerol does not disrupt fear memory processes or stressinduced anxiety in mice[J].Cannabis and Cannabinoid Research,2021:2021 Jun 28.
[44]佚名.我国成为全球首个整类列管合成大麻素类物质的国家[J].中国法医学杂志,2021,36(3):317.

Memo

基金项目:国家自然科学基金青年项目(82004489)

Last Update: 2023-11-24
Copyright @ 2020 Journal of Shaanxi University of Chinese Medicine
 Address: Middle Section of Century Avenue, Xianyang, Shaanxi Province. Post Code: 712046
Tel: 029-38185250 Fax: 029-38185250 E-mail: shxzhzs@163.com Powered by: www.editorhome.cn